Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy ...
Please provide your email address to receive an email when new articles are posted on . Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic ...
Airbus now owns 50.01% of Bombardier's advanced C Series airliner program. The US Department of Commerce has proposed a 299.45% tariff on C Series coming to the US. Airbus will now build the US-bound ...
An announcement from Ascelia Pharma AB ( ($SE:ACE) ) is now available. Ascelia Pharma’s Board of Directors has decided to convert 53,335 series C ...
On Monday, Airbus and Bombardier announced that the two airplane makers would join forces on the next-generation C Series airliner. The deal sees Airbus acquiring a 50.01% equity stake in Bombardier's ...